Penn Davis Mcfarland Inc Bristol Myers Squibb CO Transaction History
Penn Davis Mcfarland Inc
- $872 Million
- Q2 2025
A detailed history of Penn Davis Mcfarland Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penn Davis Mcfarland Inc holds 356,610 shares of BMY stock, worth $16.2 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
356,610
Previous 357,783
0.33%
Holding current value
$16.2 Million
Previous $21.8 Million
24.35%
% of portfolio
1.89%
Previous 2.63%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.68 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.2 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.9 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.3 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.01 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...